Mark David Charles

City:

Cambridge

Country:

United Kingdom

Published Applications:

Last publication date:

2022-03-17

Top Assignees for applications by Mark David Charles

The entities that hold a legal rights for patent applications filed by inventor Charles Mark David:

Cancer Research Technology Limited 9 London, United Kingdom
AstraZeneca AB 4 Sodertalje, Sweden
AstraZeneca AB 1 , Sweden
Cancer Research Technology Limited 1 , United Kingdom

Recent patent applications by Charles Mark David

Mark David Charles from Cambridge, GB has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-03-17

US20220079942A1

Human necessities

Pyrimidinone derivatives as CDC7 inhibitors

#2 | 2021-08-12

US20210246131A1

Chemistry; metallurgy

1,3,4-thiadiazole compounds and their use in treating cancer

#3 | 2020-04-23

US20200123157A1

Chemistry; metallurgy

Preparation and uses of pyrimidinone derivatives

#4 | 2019-12-26

US20190389853A1

Chemistry; metallurgy

1,3,4-thiadiazole compounds and their use in treating cancer

#5 | 2019-11-07

US20190336502A1

Human necessities

Pyrimidinone derivatives as Cdc7 inhibitors

#6 | 2018-10-25

US20180305349A1

Chemistry; metallurgy

1, 3, 4-thiadiazole compounds and their use in treating cancer

#7 | 2017-07-13

US20170197954A1

Chemistry; metallurgy

1,3,4-thiadiazole compounds and their use in treating cancer

#8 | 2017-06-01

US20170152255A1

Chemistry; metallurgy

1,3,4-thiadiazole compounds and their use in treating cancer

#9 | 2017-06-01

US20170152254A1

Chemistry; metallurgy

1,3,4-thiadiazole compounds and their use in treating cancer

InventorID:

1889655 ⎘